EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10367054" target="_blank" >RIV/00216208:11110/17:10367054 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/17:N0000041
Result on the web
<a href="http://dx.doi.org/10.1136/annrheumdis-2016-210715" target="_blank" >http://dx.doi.org/10.1136/annrheumdis-2016-210715</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1136/annrheumdis-2016-210715" target="_blank" >10.1136/annrheumdis-2016-210715</a>
Alternative languages
Result language
angličtina
Original language name
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Original language description
On the bases of evidence and Delphe method developed recommendations for therapy of rheumatoid arthritis with emphasis of application of conventional and synthetic DMARDs and biologic DMARDs including biosimilar drugs.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30226 - Rheumatology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Annals of the Rheumatic Diseases
ISSN
0003-4967
e-ISSN
—
Volume of the periodical
76
Issue of the periodical within the volume
6
Country of publishing house
GB - UNITED KINGDOM
Number of pages
18
Pages from-to
960-977
UT code for WoS article
000401138800009
EID of the result in the Scopus database
2-s2.0-85019702082